Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI.
At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships.
In this episode, Izabela Chmielewska, Kevin Grogan, and Natasha Choukkar discuss takeaways – from advancing personalized treatments to tackling the patent cliff – highlighting how Norstella empowers organizations to navigate complexity and drive innovation.
